These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11489334

  • 1. Intestinal lymphatic drug transport: an update.
    Porter CJ, Charman WN.
    Adv Drug Deliv Rev; 2001 Aug 23; 50(1-2):61-80. PubMed ID: 11489334
    [Abstract] [Full Text] [Related]

  • 2. Animal models for the study of intestinal lymphatic drug transport.
    Edwards GA, Porter CJ, Caliph SM, Khoo SM, Charman WN.
    Adv Drug Deliv Rev; 2001 Aug 23; 50(1-2):45-60. PubMed ID: 11489333
    [Abstract] [Full Text] [Related]

  • 3. A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs.
    Khoo SM, Prankerd RJ, Edwards GA, Porter CJ, Charman WN.
    J Pharm Sci; 2002 Mar 23; 91(3):647-59. PubMed ID: 11920750
    [Abstract] [Full Text] [Related]

  • 4. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs.
    Khoo SM, Shackleford DM, Porter CJ, Edwards GA, Charman WN.
    Pharm Res; 2003 Sep 23; 20(9):1460-5. PubMed ID: 14567642
    [Abstract] [Full Text] [Related]

  • 5. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.
    Trevaskis NL, Charman WN, Porter CJ.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):702-16. PubMed ID: 18155316
    [Abstract] [Full Text] [Related]

  • 6. Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.
    Porter CJ, Charman SA, Humberstone AJ, Charman WN.
    J Pharm Sci; 1996 Apr 17; 85(4):357-61. PubMed ID: 8901068
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport.
    Trevaskis NL, Caliph SM, Nguyen G, Tso P, Charman WN, Porter CJ.
    Pharm Res; 2013 Dec 17; 30(12):3254-70. PubMed ID: 23430484
    [Abstract] [Full Text] [Related]

  • 12. Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties.
    Ryšánek P, Grus T, Šíma M, Slanař O.
    Pharm Res; 2020 Aug 07; 37(9):166. PubMed ID: 32770268
    [Abstract] [Full Text] [Related]

  • 13. The role of lymphatic transport in enhancing oral protein and peptide drug delivery.
    Wasan KM.
    Drug Dev Ind Pharm; 2002 Oct 07; 28(9):1047-58. PubMed ID: 12455465
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids.
    Holm R, Müllertz A, Pedersen GP, Kristensen HG.
    Pharm Res; 2001 Sep 07; 18(9):1299-304. PubMed ID: 11683243
    [Abstract] [Full Text] [Related]

  • 16. Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats.
    Holm R, Porter CJ, Müllertz A, Kristensen HG, Charman WN.
    Pharm Res; 2002 Sep 07; 19(9):1354-61. PubMed ID: 12403073
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transport.
    Trevaskis NL, Hu L, Caliph SM, Han S, Porter CJ.
    J Vis Exp; 2015 Mar 06; (97):. PubMed ID: 25866901
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intestinal transport as a potential determinant of drug bioavailability.
    Nauli AM, Nauli SM.
    Curr Clin Pharmacol; 2013 Aug 06; 8(3):247-55. PubMed ID: 23343017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.